Podcast 127: Why QALYs matter

August 3rd, 2011

Subscribe: RSS

This time we talk with Dr. Katia Noyes, first author on a study of the cost-effectiveness of disease-modifying drugs in multiple sclerosis. If you don’t treat MS, don’t think that the topic is irrelevant. Noyes brings the issues of cost-effectiveness and the dreaded QALY into focus for clinicians who see patients.

After all, medical costs will undoubtedly become centerpieces of political debate over the next year and beyond. We’d all be better off being able to evaluate the arguments made.

Noyes et al.’s article in Neurology (abstract)
Physician’s First Watch coverage
Peter Neumann’s book, “Using Cost-Effectiveness Analysis to Improve Health Care” (Amazon link)
Gold et al.’s book, “Cost-Effectiveness in Health and Medicine” (Amazon link)

Clinical Conversations

This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.

August 3rd, 2011